Investors Buy Large Volume of Call Options on Hyperliquid Strategies (NASDAQ:PURR)

Hyperliquid Strategies Inc (NASDAQ:PURR) was the target of unusually large options trading activity on Thursday. Stock traders acquired 16,824 call options on the stock. This is an increase of approximately 34% compared to the typical daily volume of 12,567 call options.

Hyperliquid Strategies Price Performance

PURR stock traded down $0.63 during mid-day trading on Thursday, hitting $9.74. The stock had a trading volume of 12,680,034 shares, compared to its average volume of 6,995,848. Hyperliquid Strategies has a 52 week low of $3.01 and a 52 week high of $11.62. The stock has a market capitalization of $1.41 billion, a price-to-earnings ratio of -1.32 and a beta of 1.64. The stock’s fifty day moving average is $6.65.

Hyperliquid Strategies (NASDAQ:PURR) last released its earnings results on Thursday, May 7th. The company reported $1.01 EPS for the quarter. The firm had revenue of $2.63 million during the quarter. As a group, analysts anticipate that Hyperliquid Strategies will post -0.75 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of PURR. Boothbay Fund Management LLC acquired a new position in Hyperliquid Strategies during the fourth quarter worth about $40,000. XTX Topco Ltd acquired a new position in Hyperliquid Strategies during the fourth quarter worth about $48,000. Squarepoint Ops LLC acquired a new position in Hyperliquid Strategies during the fourth quarter worth about $73,000. Private Advisor Group LLC acquired a new position in Hyperliquid Strategies during the first quarter worth about $83,000. Finally, Millennium Management LLC acquired a new position in Hyperliquid Strategies during the fourth quarter worth about $87,000. Institutional investors and hedge funds own 9.45% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on PURR shares. Cantor Fitzgerald raised their target price on shares of Hyperliquid Strategies from $6.00 to $8.00 and gave the company an “overweight” rating in a research note on Monday, May 11th. Wall Street Zen raised shares of Hyperliquid Strategies to a “hold” rating in a research report on Saturday, February 21st. Maxim Group began coverage on shares of Hyperliquid Strategies in a research report on Friday, April 24th. They issued a “buy” rating and a $10.00 target price for the company. Weiss Ratings raised shares of Hyperliquid Strategies from a “sell (e)” rating to a “sell (d)” rating in a research report on Wednesday, May 20th. Finally, Chardan Capital raised their target price on shares of Hyperliquid Strategies from $8.45 to $9.75 and gave the company a “buy” rating in a report on Wednesday, May 20th. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $9.25.

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.